SABCS15 Thursday Press Conference
Dec 10, 2015•1 hr 3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Moderator: SABCS Co-director and AACR Past-president Carlos L. Arteaga, MD, director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center
- Analysis of Blood Samples Finds ESR1 Gene Mutations Are Prevalent and Associated With Worse Overall Survival;
- Breast-conserving Therapy Yielded Better Outcomes Than Mastectomy For Early-stage Patients;
- Mastectomy Plus Reconstruction has Higher Complication Rates and Costs Than Lumpectomy Plus Radiation; and
- Resistance of ER-positive Breast Cancer to Tamoxifen Therapy May be Driven by APOBEC3B.
For the best experience, listen in Metacast app for iOS or Android